gushamilton.bsky.social
@gushamilton.bsky.social
The big reveal starts. #escmidglobal
April 12, 2025 at 2:20 PM
Following up, Gunnar also shows the problems with the screening tests. It's a challenge in high R area #escmidglobal #escmid2025
April 12, 2025 at 7:44 AM
Gunnar from EUCAST talking about the complexities of susceptibility testing using oxacillin disc screening. #escmid2025
April 12, 2025 at 7:37 AM
Reposted
NEW PREPRINT!

Enjoyed working with @tom-parks.bsky.social and @petedodd24.bsky.social on immortal time bias

In its simplest form, ITB results from misallocation of person time, i.e. pre treatment time in intervention group being counted as time on treatment

www.medrxiv.org/content/10.1...

[1/n]
January 10, 2025 at 9:29 AM
We are looking for patient, clinician and researcher insight into priorities for community acquired pneumonia!

This is a JLA Priority Setting Partnership and will drive the UK research agenda for years to come - please share!!

⛄🎄⛄🎄!!

forms.office.com/Pages/Respon...
December 23, 2024 at 9:51 AM
Just a short piece on FQ prescribing. Basically, it's gone downhill, in relation to comparator antibiotics and absolutely. Still waiting for the MHRA to release the report with new information...
December 21, 2024 at 7:31 PM
Reposted
NEW LETTER! Me and @gushamilton.bsky.social argue that, if you want to demonstrate all oral treatment for pneumonia is adequate, then systematically excluding from sample people who are switched to IV after failing oral therapy is problematic

www.clinicalmicrobiologyandinfection.com/article/S119...
DEFINE_ME
www.clinicalmicrobiologyandinfection.com
December 21, 2024 at 11:32 AM
Just really cool.
Today we report that an engineered skin bacterium, swabbed gently on the head of a mouse, can unleash a potent antibody response against a pathogen. Could lead to topical vaccines that are applied in a cream. @djenetbousbaine.bsky.social led the charge... @natureportfolio.bsky.social 1/55
December 11, 2024 at 10:36 PM
What an absolutely lovely paper. Important topic. I wonder what it would cost today and how much the total cost was. Such a lovely bit of work. Will keep this for talks and presentations.
Nice write-up about our study into the 1957 Glasgow mass #TB screening campaign. #TBsky

journals.plos.org/plosmedicine...
December 11, 2024 at 10:30 PM
Interesting trial. If we took the point estimates, then we would accept 0.9 days less abx per person, for a 1.6% absolute mortality increase. Not sure I would take that. Obviously, imprecision means both of these are less precise; but I think not a clear 'win' for PCT
jamanetwork.com/journals/jam...
Biomarker-Guided Antibiotic Duration for Patients With Suspected Sepsis
This clinical trial assessed whether treatment protocols for monitoring C-reactive protein or procalcitonin safely reduced the amount of time critically ill adults with suspected sepsis received antib...
jamanetwork.com
December 10, 2024 at 3:51 PM
Not gonna disagree with a Nobel prize winner on the economics here, but people underestimate Trump and the power being crazy has. If people think he will do something crazy, they change their behaviour in funny ways(and sometimes in his favour). I don't think it's a rational play, that's the point.
It goes without saying that this is stupid, and I wonder what set it off. Was there a segment on Fox News? But I thought it might be worth a thread explaining what Trump (and, to be fair, some other international leaders) don't get about international money 1/
December 1, 2024 at 6:04 PM
What's the best book for understanding LLMs and their ilk? I understand basic statistics and computing (i.e. I can use bash, python, and HPC clusters). So something that works from there upwards. Like explains transformers.
December 1, 2024 at 1:27 PM
Reposted
Reposting for anyone who hasn't clocked this paper yet- fab analysis by @gushamilton.bsky.social @gpollara.bsky.social and team - persuaded anti-IL6 unlikely to increase TB risk , and now need to test it's potential as therapeutic to reduce immunopath. What else can we infer about TB immunology?
November 30, 2024 at 2:28 PM
uh huh
November 27, 2024 at 4:07 PM
Reposted
New research article in The Lancet Microbe

Altered IL-6 signalling and risk of #tuberculosis: a multi-ancestry mendelian randomisation study

www.thelancet.com/journals/lan...

#IDSky #MicroSky #TB #OpenAccess #OA
November 21, 2024 at 9:06 AM
Reposted
🚨 Delighted to share our paper defining a new role for IL-6 in TB. 🚨

We used genetic variation to show *reduced* IL-6 signalling is causally associated with *lower* risk of TB.

Lead author @gushamilton.bsky.social

#TBSky #IDSky #ImmunoSky www.thelancet.com/journals/lan...
Thread 👇 (1/8)
Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study
Our findings propose a causal relationship between reduced IL-6 signalling and lower risk of tuberculosis, akin to the effect seen in other IL-6 mediated diseases. This study suggests that IL-6 antago...
www.thelancet.com
November 21, 2024 at 10:30 AM
Reposted
NEW PAPER! Work led by @gushamilton.bsky.social and @gpollara.bsky.social finds reduced IL-6 signalling may REDUCE risk of TB disease

Challenges idea that IL-6 plays essential role in immunity to Mtb, and suggests that IL-6 drives immunopathology

Great use of data from ITHGC

#IDSky #EpiSky
Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study
Our findings propose a causal relationship between reduced IL-6 signalling and lower risk of tuberculosis, akin to the effect seen in other IL-6 mediated diseases. This study suggests that IL-6 antago...
www.thelancet.com
November 21, 2024 at 9:20 AM